BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 28571970)

  • 1. Oxidative imbalance in low/intermediate-1-risk myelodysplastic syndrome patients: The influence of iron overload.
    Ivars D; Orero MT; Javier K; Díaz-Vico L; García-Giménez JL; Mena S; Tormos C; Egea M; Pérez PL; Arrizabalaga B; Ruiz MÁ; Yagüe N; Tormo M; Sancho-Tello R; Gomes A; Algueró C; O'Connor JE; Sáez GT; Carbonell F; Collado R
    Clin Biochem; 2017 Nov; 50(16-17):911-917. PubMed ID: 28571970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HFE gene mutation and oxidative damage biomarkers in patients with myelodysplastic syndromes and its relation to transfusional iron overload: an observational cross-sectional study.
    De Souza GF; Ribeiro HL; De Sousa JC; Heredia FF; De Freitas RM; Martins MR; Gonçalves RP; Pinheiro RF; Magalhães SM
    BMJ Open; 2015 Apr; 5(4):e006048. PubMed ID: 25841232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress and mitochondrial dysfunction play a role in myelodysplastic syndrome development, diagnosis, and prognosis: A pilot study.
    Gonçalves AC; Cortesão E; Oliveiros B; Alves V; Espadana AI; Rito L; Magalhães E; Lobão MJ; Pereira A; Nascimento Costa JM; Mota-Vieira L; Sarmento-Ribeiro AB
    Free Radic Res; 2015; 49(9):1081-94. PubMed ID: 25968944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial dysfunction, persistent oxidative damage, and catalase inhibition in immune cells of naïve and treated Crohn's disease.
    Beltrán B; Nos P; Dasí F; Iborra M; Bastida G; Martínez M; O'Connor JE; Sáez G; Moret I; Ponce J
    Inflamm Bowel Dis; 2010 Jan; 16(1):76-86. PubMed ID: 19637347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study of oxidative stress in advanced kidney disease].
    Puchades Montesa MJ; González Rico MA; Solís Salguero MA; Torregrosa Maicas I; Tormos Muñoz MC; Saez Tormo G; Juan Garcia I; Miguel Carrasco A
    Nefrologia; 2009; 29(5):464-73. PubMed ID: 19820759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Oxidative Stress and Antioxidant Status in Chronic Obstructive Pulmonary Disease.
    Singh S; Verma SK; Kumar S; Ahmad MK; Nischal A; Singh SK; Dixit RK
    Scand J Immunol; 2017 Feb; 85(2):130-137. PubMed ID: 28256060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current understanding of iron overload hazard in patients with myelodysplastic syndrome].
    Song LX; Su JY; Zhang Z; Chang CK
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):484-8. PubMed ID: 23628060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron overload-induced oxidative stress in myelodysplastic syndromes and its cellular sequelae.
    Kim CH; Leitch HA
    Crit Rev Oncol Hematol; 2021 Jul; 163():103367. PubMed ID: 34058341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute iron overload and oxidative stress in brain.
    Piloni NE; Fermandez V; Videla LA; Puntarulo S
    Toxicology; 2013 Dec; 314(1):174-82. PubMed ID: 24120471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress markers in the neocortex of drug-resistant epilepsy patients submitted to epilepsy surgery.
    Rumià J; Marmol F; Sanchez J; Giménez-Crouseilles J; Carreño M; Bargalló N; Boget T; Pintor L; Setoain X; Donaire A; Saez GT; Ribalta T; Ferrer E; Puig-Parellada P
    Epilepsy Res; 2013 Nov; 107(1-2):75-81. PubMed ID: 24054426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxidative stress and antioxidant enzymes in children with beta-thalassemia major.
    Naithani R; Chandra J; Bhattacharjee J; Verma P; Narayan S
    Pediatr Blood Cancer; 2006 Jun; 46(7):780-5. PubMed ID: 16317757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative stress and antioxidant enzyme activity in South Indian male smokers with chronic obstructive pulmonary disease.
    Arja C; Surapaneni KM; Raya P; Adimoolam C; Balisetty B; Kanala KR
    Respirology; 2013 Oct; 18(7):1069-75. PubMed ID: 23683270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron overload may promote alteration of NK cells and hematopoietic stem/progenitor cells by JNK and P38 pathway in myelodysplastic syndromes.
    Hua Y; Wang C; Jiang H; Wang Y; Liu C; Li L; Liu H; Shao Z; Fu R
    Int J Hematol; 2017 Aug; 106(2):248-257. PubMed ID: 28405919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of iron overload in myelodysplastic syndromes.
    Fenaux P; Rose C
    Blood Rev; 2009 Dec; 23 Suppl 1():S15-9. PubMed ID: 20116635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative damage and antioxidant defense in thymus of malnourished lactating rats.
    Gavia-García G; González-Martínez H; Miliar-García Á; Bonilla-González E; Rosas-Trejo Mde L; Königsberg M; Nájera-Medina O; Luna-López A; González-Torres MC
    Nutrition; 2015; 31(11-12):1408-15. PubMed ID: 26429663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutathione and antioxidant enzymes serve complementary roles in protecting activated hepatic stellate cells against hydrogen peroxide-induced cell death.
    Dunning S; Ur Rehman A; Tiebosch MH; Hannivoort RA; Haijer FW; Woudenberg J; van den Heuvel FA; Buist-Homan M; Faber KN; Moshage H
    Biochim Biophys Acta; 2013 Dec; 1832(12):2027-34. PubMed ID: 23871839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antioxidant intervention attenuates oxidative stress in children and teenagers with Down syndrome.
    Parisotto EB; Garlet TR; Cavalli VL; Zamoner A; da Rosa JS; Bastos J; Micke GA; Fröde TS; Pedrosa RC; Wilhelm Filho D
    Res Dev Disabil; 2014 Jun; 35(6):1228-36. PubMed ID: 24685938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Case-Control Study of Involvement of Oxidative DNA Damage and Alteration of Antioxidant Defense System in Patients with Basal Cell Carcinoma: Modulation by Tumor Removal.
    Chaisiriwong L; Wanitphakdeedecha R; Sitthinamsuwan P; Sampattavanich S; Chatsiricharoenkul S; Manuskiatti W; Panich U
    Oxid Med Cell Longev; 2016; 2016():5934024. PubMed ID: 27057281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antioxidant defence system during exponential and stationary growth phases of Phycomyces blakesleeanus: response to oxidative stress by hydrogen peroxide.
    de Castro C; del Valle P; Rúa J; García-Armesto MR; Gutiérrez-Larraínzar M; Busto F; de Arriaga D
    Fungal Biol; 2013 Apr; 117(4):275-87. PubMed ID: 23622722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Iron chelation therapy and its influence on the alleviation of EPO resistance in MDS patients].
    Zhang Y; Xiao C; Gu SC; Chang CK
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):1027-32. PubMed ID: 25130822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.